NVRO Stock Overview
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
NewNotes are coming soon
Nevro Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$36.68 |
| 52 Week High | US$78.90 |
| 52 Week Low | US$34.70 |
| Beta | 0.82 |
| 1 Month Change | -5.97% |
| 3 Month Change | -5.56% |
| 1 Year Change | -40.59% |
| 3 Year Change | -72.40% |
| 5 Year Change | -53.87% |
| Change since IPO | 45.61% |
Recent News & Updates
Does Nevro (NYSE:NVRO) Have A Healthy Balance Sheet?
Jan 13
Nevro: Opportunity Overshadowed By Weaknesses
Dec 07Recent updates
Does Nevro (NYSE:NVRO) Have A Healthy Balance Sheet?
Jan 13Is Nevro (NYSE:NVRO) Weighed On By Its Debt Load?
Oct 02Is Nevro (NYSE:NVRO) Weighed On By Its Debt Load?
Jun 17Nevro (NYSE:NVRO) Has Debt But No Earnings; Should You Worry?
Feb 07Is Nevro (NYSE:NVRO) Using Too Much Debt?
Aug 03Nevro Corp.'s (NYSE:NVRO) Shift From Loss To Profit
May 07Nevro (NYSE:NVRO) Has Debt But No Earnings; Should You Worry?
Apr 17Have Insiders Been Selling Nevro Corp. (NYSE:NVRO) Shares?
Mar 16Introducing Nevro (NYSE:NVRO), The Stock That Zoomed 271% In The Last Five Years
Feb 09
Should You Investigate Nevro Corp. (NYSE:NVRO) At US$180?
Jan 22Is Nevro (NYSE:NVRO) Using Debt Sensibly?
Jan 04Shareholder Returns
| NVRO | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -3.3% | -0.1% | 2.3% |
| 1Y | -40.6% | -9.6% | -9.7% |
Return vs Industry: NVRO underperformed the US Medical Equipment industry which returned -9.6% over the past year.
Return vs Market: NVRO underperformed the US Market which returned -9.7% over the past year.
Price Volatility
| NVRO volatility | |
|---|---|
| NVRO Average Weekly Movement | 8.4% |
| Medical Equipment Industry Average Movement | 8.8% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in US Market | 17.3% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: NVRO is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 8% a week.
Volatility Over Time: NVRO's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 945 | D. Grossman | https://www.nevro.com |
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence.
Nevro Corp. Fundamentals Summary
| NVRO fundamental statistics | |
|---|---|
| Market Cap | US$1.29b |
| Earnings (TTM) | -US$7.94m |
| Revenue (TTM) | US$395.28m |
3.3x
P/S Ratio-163.7x
P/E RatioIs NVRO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NVRO income statement (TTM) | |
|---|---|
| Revenue | US$395.28m |
| Cost of Revenue | US$125.02m |
| Gross Profit | US$270.26m |
| Other Expenses | US$278.20m |
| Earnings | -US$7.94m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
Feb 16, 2023
| Earnings per share (EPS) | -0.22 |
| Gross Margin | 68.37% |
| Net Profit Margin | -2.01% |
| Debt/Equity Ratio | 57.4% |
How did NVRO perform over the long term?
See historical performance and comparison